Ifosfamide For Injection IP With Mesna Injection

Name: Ifosfamide For Injection IP With Mesna Injection
Brand: NEETCO BIOPHARMA
Price: 300 INR
Availability: InStock

Price 300 INR/ Vial

Get a Price/Quote

MOQ : 1 Vial

Ifosfamide For Injection IP With Mesna Injection Specification

Dosage Form
Injection (Lyophilized Powder for Reconstitution)

Salt Composition
Ifosfamide IP 1 gm with Mesna IP 1 gm (as separate vials in the kit)

Indication
Testicular cancer and other solid tumorsusually in combination chemotherapy

Enzyme Types
Not applicable (cytotoxic alkylating agent and uroprotective adjuvant)

Feature

Ingredients
Ifosfamide, Mesna (sodium 2-mercaptoethane sulfonate)

Application
Hospital/Clinical - Intravenous use under medical supervision

Ph Level
Neutral to slightly alkaline after reconstitution

Physical Color/Texture
Ifosfamide: White to off-white powder; Mesna: White or almost white powder

Fermentation Smell
Odorless or faint characteristic (non-fermentative product)

Storage Instructions
Store below 25C. Protect from light. Do not freeze. Use immediately after reconstitution.

Shelf Life
24 months from the date of manufacture

About Ifosfamide For Injection IP With Mesna Injection

Last Chance to obtain the acclaimed Ifosfamide For Injection IP with Mesna Injection-an expertly formulated, sterile kit for hospital oncology settings. Utilise this offer to access a lustrous combination therapy trusted for managing testicular cancer and other grandiose solid tumors. Each preeminent kit includes 1 gm Ifosfamide vial and 1 gm Mesna vial, both lyophilized for reconstitution and intravenous use by specialists. Compatible with 0.9% NaCl or D5W, this generic and branded medication meets stringent IP/BP/USP compliance. Dispose as per cytotoxic guidelines. Prescription only. For professional use.

Targeted Oncology Support with Advanced Site-Specific Administration

Ifosfamide For Injection IP With Mesna Injection is designed for intravenous application in a hospital or clinical setting. Primarily used for treating testicular cancer and other solid tumors as part of combination chemotherapy, this respected kit offers vital uroprotection with Mesna. Key competitive advantages include its sterile, dual-vial system, compatibility with common diluents, and its status as both a branded and generic medication. Healthcare professionals rely on its proven efficacy and strict regulatory adherence.

High Supply Reliability and Certified Excellence for Distributors

Our supply capacity ensures consistent availability of Ifosfamide For Injection IP With Mesna Injection across various regions, with full compliance to IP/BP/USP certifications. The asking price is competitive, supporting bulk orders via major FOB ports in India. Benefit from expedited express shipping and flexible drop-off options tailored to distributor and exporter needs. Each kit is batch-tracked and adheres to international shipment standards, delivering both safety and quality assurance.

FAQ's of Ifosfamide For Injection IP With Mesna Injection:

Q: How is Ifosfamide For Injection IP With Mesna Injection administered?

A: This kit is intended for intravenous administration and should only be prepared and administered by qualified healthcare professionals in a hospital or clinical setting, following the recommended reconstitution and dilution guidelines.

Q: What are the primary indications for using Ifosfamide with Mesna?

A: Ifosfamide with Mesna is primarily indicated for the treatment of testicular cancer and other solid tumors, where it is commonly used as part of combination chemotherapy regimens.

Q: When should the reconstituted medication be used?

A: Once reconstituted, the injection should be used immediately to maintain sterility and efficacy. Any unused product must be disposed of as per cytotoxic waste guidelines.

Q: Where is this product typically supplied from and what packaging is used?

A: The product is distributed from certified facilities in India, using glass vials with a secure flip-top seal for safety and product integrity.

Q: What are the primary benefits of the combination kit?

A: The kit offers a ready-to-use combination of cytotoxic chemotherapy (Ifosfamide) and uroprotective adjuvant (Mesna), enhancing patient safety and treatment outcomes during chemotherapy.

Q: How should unused or waste materials from this kit be disposed of?

A: All unused product and related waste materials must be disposed of in accordance with cytotoxic waste management protocols to ensure environmental and personnel safety.

Tell us about your requirement